Home ›  Medical Devices ›  Report Detail

Canada In Vitro Diagnostics Market Outlook to 2016

Published: July 2010
No. of Pages: 205
  

Report Summary

GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Canada In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.Scope

  • Market size and company share data for In Vitro Diagnostics (IVD) market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
  • 2009 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the Canada In Vitro Diagnostics (IVD) market.
  • Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Canada In Vitro Diagnostics (IVD) competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Canada In Vitro Diagnostics Market Outlook to 2016

1 Table of Contents
 
1.1 List of Tables
1.2 List of Figures
 
2 Introduction
2.1 What is This Report About?
 
3 In Vitro Diagnostics In Canada
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, Canada, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, Canada, Company Share (2008-2009)
 
4 Clinical Chemistry In Canada
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Canada, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, Canada, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
4.4.2 Urine Analysis Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, Canada, Company Share (2008-2009)
 
5 Genetic Testing In Canada
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Canada, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, Canada, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, Canada, Company Share (2008-2009)
 
6 Haematology In Canada
6.1 Haematology, Market Segmentation
6.2 Haematology Market, Canada, Revenue Mix ($m), 2009
6.3 Haematology Market, Canada, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.4.1 Haematology Reagents Revenue (2002-2016)
6.4.2 Immunohaematology Revenue (2002-2016)
6.4.3 Haemostasis Revenue (2002-2016)
6.4.4 Haematology Rapid Tests Revenue (2002-2016)
6.4.5 Haematology Cell Counters Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, Canada, Company Share (2008-2009)
 
7 Histology And Cytology In Canada
7.1 Histology and Cytology, Market Segmentation
7.2 Histology and Cytology Market, Canada, Revenue Mix ($m), 2009
7.3 Histology And Cytology Market, Canada, Category Contribution (%), 2009
7.4 Histology And Cytology Overall Revenue (2002-2016)
7.4.1 Histology Revenue (2002-2016)
7.5 Histology And Cytology Distribution Share (2008-2009)
7.6 Histology And Cytology, Canada, Company Share (2008-2009)
 
8 Immuno Chemistry In Canada
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, Canada, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, Canada, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
8.4.2 Drug Related Testing Revenue (2002-2016)
8.4.3 Endocrinology Tests Revenue (2002-2016)
8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, Canada, Company Share (2008-2009)
 
9 Infectious Immunology In Canada
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Canada, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, Canada, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, Canada, Company Share (2008-2009)
 
10 Microbiology Culture In Canada
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Canada, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, Canada, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.4.1 Microbiology Analyzers Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, Canada, Company Share (2008-2009)
 
11 Overview of Key Companies in Canada In Vitro Diagnostics Market
11.1 Siemens Healthcare
11.1.1 Company Overview
11.1.2 Share in the Canada In Vitro Diagnostics Market
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Share in the Canada In Vitro Diagnostics Market
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 Company Overview
11.3.2 Share in the Canada In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
11.4.1 Company Overview
11.4.2 Share in the Canada In Vitro Diagnostics Market
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.5.2 Share in the Canada In Vitro Diagnostics Market
11.6 Inverness Medical Innovations, Inc.
11.6.1 Company Overview
11.6.2 Share in the Canada In Vitro Diagnostics Market
11.7 Becton, Dickinson and Company
11.7.1 Company Overview
11.8 bioMerieux S.A.
11.8.1 Company Overview
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Company Overview
11.10 Hologic, Inc.
11.10.1 Company Overview
11.11 OLYMPUS CORPORATION
11.11.1 Company Overview
11.12 Mindray Medical International Limited
11.12.1 Company Overview
11.13 Sysmex Corporation
11.13.1 Company Overview
11.14 DiaSorin S.p.A
11.14.1 Company Overview
11.15 Qiagen N.V.
11.15.1 Company Overview
11.16 Gen-Probe Incorporated
11.16.1 Company Overview
11.17 Phadia AB
11.17.1 Company Overview
11.18 DiagnoCure Inc.
11.18.1 Company Overview
11.19 SQI Diagnostics Inc.
11.19.1 Company Overview
11.20 Biocore Systems Inc.
11.20.1 Company Overview
11.21 BioCurex, Inc.
11.21.1 Company Overview
11.22 Cedarlane Laboratories Limited
11.22.1 Company Overview
11.23 Xceed Molecular
11.23.1 Company Overview
11.24 Epocal Inc.
11.24.1 Company Overview
11.25 Somagen Diagnostics Inc.
11.25.1 Company Overview
11.26 bioLytical Laboratories Inc.
11.26.1 Company Overview
11.27 NuGen Biotech (Canada)
11.27.1 Company Overview
11.28 Med BioGene Inc.
11.28.1 Company Overview
 
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
 
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 LabCorp Sells Minority Stake In Ontario, Canada Joint Venture
13.1.2 LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture
13.1.3 Inverness Medical Innovations To Acquire Epocal
13.1.4 Calotto Capital Merges With Hamilton Thorne In Reverse Transaction
13.2 Partnerships
13.2.1 Abbott Laboratories Enters Into An Agreement With GlaxoSmithKline
13.2.2 QIAGEN Enters Into Distribution Agreement With Celera
13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
13.2.4 Centre for Addiction and Mental Health Enters Into Licensing Agreement With Athena Diagnostics
13.2.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
13.2.6 Myconostica Enters Into Distribution Agreement With Inverness Medical Canada
13.2.7 Miraculins Enters Into An Agreement With Inverness Medical Innovations
13.2.8 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
 
14 Recent Developments
14.1 Legal and Regulatory
14.1.1 Dec 08, 2009: HairDX Files Lawsuit Against Speedwinds Nuitrition And CJ Thompson
14.2 Product News
14.2.1 Jun 21, 2010: CardioGenics Selects Four Clinical Test Sites For QL Care Analyzer
14.2.2 Jun 17, 2010: PHRU Utilizes MedMira’s Reveal Rapid HIV Antibody Test
14.2.3 Jun 03, 2010: GeneNews Announces Malaysian Study Further Validates Its ColonSentry Test
14.2.4 May 17, 2010: Miraculins Develops Ultrasensitive Assay For Soluble Endoglin
14.2.5 May 17, 2010: Response Biomedical Receives Class III Medical Device License By Health Canada To Market RSV Assay In Canada
14.2.6 Apr 19, 2010: Atherotech To Showcase VAP Cholesterol Test At ACP Annual Scientific Meeting
14.2.7 Feb 23, 2010: IL Announces FDA 510(K) And Health Canada Approval For HemosIL D-Dimer HS 500 Assay
14.2.8 Feb 23, 2010: Pacific Biosciences Commercializes SMRT DNA Sequencing System
14.2.9 Jan 27, 2010: CardioGenics Completes Self-Metering Cartridge Design For QL Care Analyzer
 
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer
 
1.1 List of Tables
 
Table 1: In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016
Table 2: In Vitro Diagnostics Market, Canada, Category Contribution (%), 2009
Table 3: In Vitro Diagnostics, Canada, Cross-Category Analysis, 2002-2016
Table 4: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2002-2009
Table 5: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2009-2016
Table 6: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), 2008-2009
Table 7: Clinical Chemistry Market, Canada, Category Contribution (%), 2009
Table 8: Clinical Chemistry, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 9: Clinical Chemistry, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 10: Clinical Chemisty Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 11: Clinical Chemisty Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 12: Urine Analysis, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 13: Urine Analysis, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 14: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 15: Clinical Chemistry, Canada, Company Share by Revenue ($m), 2008-2009
Table 16: Genetic Testing Market, Canada, Category Contribution (%), 2009
Table 17: Genetic Testing, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 18: Genetic Testing, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 19: Genetic Testing, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 20: Genetic Testing, Canada, Company Share by Revenue ($m), 2008-2009
Table 21: Haematology Market, Canada, Category Contribution (%), 2009
Table 22: Haematology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 23: Haematology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 24: Haematology Reagents, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 25: Haematology Reagents, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 26: Immunohaematology, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 27: Immunohaematology, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 28: Haemostasis, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 29: Haemostasis, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 30: Haematology Rapid Tests, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 31: Haematology Rapid Tests, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 32: Haematology Cell Counters, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 33: Haematology Cell Counters, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 34: Haematology, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 35: Haematology, Canada, Company Share by Revenue ($m), 2008-2009
Table 36: Histology And Cytology Market, Canada, Category Contribution (%), 2009
Table 37: Histology And Cytology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 38: Histology And Cytology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 39: Histology, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 40: Histology, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 41: Histology And Cytology, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 42: Histology And Cytology, Canada, Company Share by Revenue ($m), 2008-2009
Table 43: Immuno Chemistry Market, Canada, Category Contribution (%), 2009
Table 44: Immuno Chemistry, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 45: Immuno Chemistry, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 46: Disease Specific Immunochemistry, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 47: Disease Specific Immunochemistry, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 48: Drug Related Testing, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 49: Drug Related Testing, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 50: Endocrinology Tests, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 51: Endocrinology Tests, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 52: Immunochemistry Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 53: Immunochemistry Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 54: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 55: Immuno Chemistry, Canada, Company Share by Revenue ($m), 2008-2009
Table 56: Infectious Immunology Market, Canada, Category Contribution (%), 2009
Table 57: Infectious Immunology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 58: Infectious Immunology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 59: Infectious Immunology, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 60: Infectious Immunology, Canada, Company Share by Revenue ($m), 2008-2009
Table 61: Microbiology Culture Market, Canada, Category Contribution (%), 2009
Table 62: Microbiology Culture, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Table 63: Microbiology Culture, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Table 64: Microbiology Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 65: Microbiology Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 66: Microbiology Culture, Canada, Distribution Share by Revenue ($m), 2008-2009
Table 67: Microbiology Culture, Canada, Company Share by Revenue ($m), 2008-2009
Table 68: Clinical Chemisty Market Pipeline Products
Table 69: Immuno Chemistry Market Pipeline Products
Table 70: Haematology Market Pipeline Products
Table 71: Infectious Immunology Market Pipeline Products
Table 72: Microbiology Culture Market Pipeline Products
Table 73: Histology and Cytology Market Pipeline Products
Table 74: Genetic Testing Market Pipeline Products
Table 75: LabCorp Sells Minority Stake In Ontario, Canada Joint Venture
Table 76: LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture
Table 77: Inverness Medical Innovations To Acquire Epocal
Table 78: Calotto Capital Merges With Hamilton Thorne In Reverse Transaction
Table 79: Abbott Laboratories Enters Into An Agreement With GlaxoSmithKline
Table 80: QIAGEN Enters Into Distribution Agreement With Celera
Table 81: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
Table 82: Centre for Addiction and Mental Health Enters Into Licensing Agreement With Athena Diagnostics
Table 83: OraSure Technologies Enters Into An Agreement With Roche Diagnostics
Table 84: Myconostica Enters Into Distribution Agreement With Inverness Medical Canada
Table 85: Miraculins Enters Into An Agreement With Inverness Medical Innovations
Table 86: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
Table 87: USD to Local Currency, Canada, Average Actual Rate 2002-2009
 
1.2 List of Figures
 
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016
Figure 3: In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2009
Figure 4: In Vitro Diagnostics Market, Canada, Category Contribution (%), 2009
Figure 5: In Vitro Diagnostics, Canada, Cross-Category Analysis, 2002-2016
Figure 6: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2002-2009
Figure 7: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2009-2016
Figure 8: In Vitro Diagnostics, Canada, Company Share (%), 2009
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, Canada, Revenue Mix ($m), 2009
Figure 11: Clinical Chemistry Market, Canada, Category Contribution (%), 2009
Figure 12: Clinical Chemistry, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 13: Clinical Chemistry, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 14: Clinical Chemisty Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 15: Clinical Chemisty Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 16: Urine Analysis, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 17: Urine Analysis, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 18: Clinical Chemistry, Canada, Company Share (%), 2009
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, Canada, Revenue Mix ($m), 2009
Figure 21: Genetic Testing Market, Canada, Category Contribution (%), 2009
Figure 22: Genetic Testing, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 23: Genetic Testing, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 24: Genetic Testing, Canada, Company Share (%), 2009
Figure 25: Haematology, Market Segmentation
Figure 26: Haematology Market, Canada, Revenue Mix ($m), 2009
Figure 27: Haematology Market, Canada, Category Contribution (%), 2009
Figure 28: Haematology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 29: Haematology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 30: Haematology Reagents, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 31: Haematology Reagents, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 32: Immunohaematology, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 33: Immunohaematology, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 34: Haemostasis, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 35: Haemostasis, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 36: Haematology Rapid Tests, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 37: Haematology Rapid Tests, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 38: Haematology Cell Counters, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 39: Haematology Cell Counters, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 40: Haematology, Canada, Company Share (%), 2009
Figure 41: Histology And Cytology, Market Segmentation
Figure 42: Histology And Cytology Market, Canada, Revenue Mix ($m), 2009
Figure 43: Histology And Cytology Market, Canada, Category Contribution (%), 2009
Figure 44: Histology And Cytology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 45: Histology And Cytology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 46: Histology, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 47: Histology, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 48: Histology And Cytology, Canada, Company Share (%), 2009
Figure 49: Immuno Chemistry, Market Segmentation
Figure 50: Immuno Chemistry Market, Canada, Revenue Mix ($m), 2009
Figure 51: Immuno Chemistry Market, Canada, Category Contribution (%), 2009
Figure 52: Immuno Chemistry, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 53: Immuno Chemistry, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 54: Disease Specific Immunochemistry, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 55: Disease Specific Immunochemistry, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 56: Drug Related Testing, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 57: Drug Related Testing, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 58: Endocrinology Tests, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 59: Endocrinology Tests, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 60: Immunochemistry Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 61: Immunochemistry Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 62: Immuno Chemistry, Canada, Company Share (%), 2009
Figure 63: Infectious Immunology, Market Segmentation
Figure 64: Infectious Immunology Market, Canada, Revenue Mix ($m), 2009
Figure 65: Infectious Immunology Market, Canada, Category Contribution (%), 2009
Figure 66: Infectious Immunology, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 67: Infectious Immunology, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 68: Infectious Immunology, Canada, Company Share (%), 2009
Figure 69: Microbiology Culture, Market Segmentation
Figure 70: Microbiology Culture Market, Canada, Revenue Mix ($m), 2009
Figure 71: Microbiology Culture Market, Canada, Category Contribution (%), 2009
Figure 72: Microbiology Culture, Canada, Revenue ($m) by Segment , Historic, 2002-2009
Figure 73: Microbiology Culture, Canada, Revenue ($m) by Segment , Forecast, 2009-2016
Figure 74: Microbiology Analyzers, Canada, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 75: Microbiology Analyzers, Canada, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 76: Microbiology Culture, Canada, Company Share (%), 2009
Figure 77: Siemens Healthcare, Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 78: Abbott Laboratories, Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 79: F. Hoffmann-La Roche Ltd., Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 80: Beckman Coulter, Inc., Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 81: Ortho-Clinical Diagnostics Inc., Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 82: Inverness Medical Innovations, Inc., Company Share (%),Canada In Vitro Diagnostics Market, 2009
Figure 83: GlobalData Methodology
Published By: GlobalData
Product Code: GlobalData3519


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Connect With Us
link
Follow ReportsnReports.com on Twitter
ReportsnReports.com RSS
ReportsnReports.com blog
ReportsnReports.com on google plus
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100